4Q FY26 Quarterly Activity Report and Appendix 4C

Summary by 6ix AI

The report indicates a decline in revenue and profit compared to the previous corresponding period, attributed to challenges in the pharmaceutical budget cycle. Despite these challenges, the company achieved cash flow break-even and reported a net cash position at the end of the period.

Written by 6ix AI from the company’s filing. How 6ix writes summaries